"There have been six reports of a severe stroke-like illness due to low platelet count and more than six million doses of the Johnson and Johnson vaccine have been administered so far," Schuchat said. To put the numbers in context, the six reported events occurred among millions of people who received the Johnson and Johnson vaccine to date. Not all of the six women involved in the events had a pre-existing condition or risk factor, Schuchat said. In contrast, the headaches associated with these blood clots come 1 to 2 weeks later and were very severe.
Headache is a common side effect of COVID-19 vaccination, Marks added, but it typically happens within a day or two. If health care providers see people with these symptoms along with a low platelet count or blood clots, they should ask about any recent vaccinations, Marks added. "The issue here with these types of blood clots is that if one administers the standard treatment we give for blood clots, one can cause tremendous harm or it can be fatal," said Peter Marks, MD, director of the FDA Center for Biologics Evaluation and Research. Importantly, treatment for traditional blod clots, such as the drug heparin, should not be used for these clots. All six cases arose within 6 to 13 days of receipt of the Johnson and Johnson vaccine. Headache, leg pain, abdominal pain and shortness of breath were among the reported symptoms. "For people who recently got the vaccine, in the last couple of weeks, look for symptoms." "For people who got the vaccine more than one month ago, the risk is very low at this time," she added. "I know the information today will be very concerning to Americans who have already received the Johnson and Johnson vaccine," said Anne Schuchat, MD, principal deputy director at the CDC.
Of the six reported cases linked to the Johnson and Johnson vaccine, all are in women between the ages of 18 and 48 years, one woman died and another ended up in critical condition.
0 kommentar(er)
